---
schema_version: "secwatch.filing_event.v1"
accession: "0001555280-24-000141"
form_type: "8-K"
ticker: "ZTS"
cik: "0001555280"
company_name: "Zoetis Inc."
filed_at: "2024-02-13T23:59:59+00:00"
generated_at: "2026-06-06T03:22:48.586241+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Zoetis Q4 2023 revenue $2.2B (+8%), adj. EPS $1.24; FY2024 guidance $9.075-9.225B

## Summary
- Q4 revenue $2.2B (+8% reported & operational); net income $525M ($1.14 diluted EPS), up 14% and 15% respectively.
- Adjusted net income Q4 $569M ($1.24 diluted EPS), up 6% operational.
- FY 2023 revenue $8.5B (+6% reported, +7% operational); net income $2.3B ($5.07 diluted EPS).
- FY 2024 guidance: revenue $9.075-9.225B (operational growth 7-9%); adjusted diluted EPS $5.74-5.84.
- Key growth drivers: Librela, Simparica Trio, dermatology; new approvals for Solensia in Brazil and Simparica Trio in China.

## SEC filing metadata
- accession: 0001555280-24-000141
- form_type: 8-K
- ticker: ZTS
- cik: 0001555280
- company_name: Zoetis Inc.
- filed_at: 2024-02-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1555280/000155528024000141/0001555280-24-000141-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1555280/000155528024000141/zts-20240213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001555280-24-000141
- JSON: https://secwatch.observer/filing/0001555280-24-000141.json
- Plain text: https://secwatch.observer/filing/0001555280-24-000141.txt

## Key facts
- Earnings Releases
  Zoetis Inc. reported full year 2023 results: revenue $8.5 Billion, net income $2.3 Billion, EPS $5.07 per Diluted Share. Guidance initiated.
  - Period: full year 2023
  - Revenue: $8.5 Billion
  - Net income: $2.3 Billion
  - EPS: $5.07 per Diluted Share
  - Guidance: initiated
  - Result: reported results
  source text: For Full Year 2023, Zoetis Reports Revenue of $8.5 Billion, Growing 6%, and Net Income of $2.3 Billion, or $5.07 per Diluted Share, Increasing 11% and 13%, Respectively, on a Reported Basis
  evidence_url: https://www.sec.gov/Archives/edgar/data/1555280/000155528024000141/0001555280-24-000141-index.htm
- Earnings Releases
  Zoetis Inc. reported full year 2024 results: revenue $9.075 - $9.225 Billion, EPS $5.34 to $5.44 on a Reported Basis, or $5.74 to $5.84 on an Adjusted Basis. Guidance initiated.
  - Period: full year 2024
  - Revenue: $9.075 - $9.225 Billion
  - EPS: $5.34 to $5.44 on a Reported Basis, or $5.74 to $5.84 on an Adjusted Basis
  - Guidance: initiated
  - Result: guidance update
  source text: Provides Full Year 2024 Revenue Guidance of $9.075 - $9.225 Billion, with Diluted EPS of $5.34 to $5.44 on a Reported Basis, or $5.74 to $5.84 on an Adjusted Basis
  evidence_url: https://www.sec.gov/Archives/edgar/data/1555280/000155528024000141/0001555280-24-000141-index.htm
- Earnings Releases
  Zoetis Inc. reported the fourth quarter and full year 2023 results: revenue $2.2 billion, net income $525 million, EPS $1.14 per diluted share. Guidance initiated.
  - Period: the fourth quarter and full year 2023
  - Revenue: $2.2 billion
  - Net income: $525 million
  - EPS: $1.14 per diluted share
  - Guidance: initiated
  - Result: reported results
  source text: Zoetis Reports Fourth Quarter and Full Year 2023 Results • For Fourth Quarter 2023, Zoetis Reports Revenue of $2.2 Billion, Growing 8%, and Net Income of $525 Million, or $1.14 per Diluted Share, Increasing 14% and 15%, Respectively, on a Reported Basis
  evidence_url: https://www.sec.gov/Archives/edgar/data/1555280/000155528024000141/0001555280-24-000141-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.